Jurij Hanžel

38PUBLICATIONS
101CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Central and Eastern European languages (incl. Russian)Agricultural molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|May 30, 2026
Biologics and small molecules for perianal Crohn's disease: a systematic review and meta-analyses of randomized placebo-controlled trials.

|Mar 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitis.

Emmanuel Niyigena, Yannick Hoffert, Waqqas Afif

|Dec 01, 2025
An evaluation of guselkumab for the treatment of ulcerative colitis.

Jurij Hanzel, Vipul Jairath, Brian G Feagan

|Aug 06, 2024
Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease.

Florian Rieder, Christopher Ma, Jurij Hanzel

|Jul 01, 2024
Differences Between the 2016 and 2022 Food and Drug Administration Guidance-Implications for Design and Interpretation of Clinical Trials in Ulcerative Colitis.

Jurij Hanzel, Christopher Ma, Laurent Peyrin-Biroulet

|Jun 15, 2024
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.

Michel Adamina, Silvia Minozzi, Janindra Warusavitarne

Pageof 7

Frequent Collaborators

14 joint publications

Christopher Ma

9 joint publications

Vipul Jairath

6 joint publications

David Drobne

6 joint publications

Peter Bossuyt